These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17266036)
1. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo. Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells. Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775 [TBL] [Abstract][Full Text] [Related]
3. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells. Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271 [TBL] [Abstract][Full Text] [Related]
4. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin. Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888 [TBL] [Abstract][Full Text] [Related]
5. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13). Cui SX; Zhang HL; Xu WF; Qu XJ Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845 [TBL] [Abstract][Full Text] [Related]
6. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice. Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor. Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494 [TBL] [Abstract][Full Text] [Related]
8. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer. Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676 [TBL] [Abstract][Full Text] [Related]
9. Preliminary detection of the anti‑tumour activity of indoline‑2,3‑dione derivative DH‑12a targeting aminopeptidase N. Cui DX; Wang XJ; Zhang XR; Zhao TK; Guo XX; Liu SM; Wang B; Ma WQ; Gao ZQ Mol Med Rep; 2014 Nov; 10(5):2681-8. PubMed ID: 25216231 [TBL] [Abstract][Full Text] [Related]
10. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition. Sun ZP; Zhang J; Shi LH; Zhang XR; Duan Y; Xu WF; Dai G; Wang XJ Biomed Pharmacother; 2015 Dec; 76():65-72. PubMed ID: 26653552 [TBL] [Abstract][Full Text] [Related]
11. Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression. Kato M; Azuma H; Akaike M; Iuchi T; Aihara K; Ikeda Y; Fujimura M; Yoshida T; Yamaguchi H; Hashizume S; Matsumoto T Atherosclerosis; 2005 Nov; 183(1):49-55. PubMed ID: 16216591 [TBL] [Abstract][Full Text] [Related]
12. Expression, regulation and functional activities of aminopeptidase N (EC 3.4.11.2; APN; CD13) on murine macrophage J774 cell line. Gabrilovac J; Cupić B; Zivković E; Horvat L; Majhen D Immunobiology; 2011; 216(1-2):132-44. PubMed ID: 20638153 [TBL] [Abstract][Full Text] [Related]
13. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016 [TBL] [Abstract][Full Text] [Related]
14. Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines. Liang W; Gao B; Xu G; Weng D; Xie M; Qian Y Int J Oncol; 2014 Dec; 45(6):2475-85. PubMed ID: 25340499 [TBL] [Abstract][Full Text] [Related]
15. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN). Ma C; Jin K; Cao J; Zhang L; Li X; Xu W Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219 [TBL] [Abstract][Full Text] [Related]
16. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model. Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors. Zhang X; Zhang L; Zhang J; Feng J; Yuan Y; Fang H; Xu W J Enzyme Inhib Med Chem; 2013 Jun; 28(3):545-51. PubMed ID: 22380779 [TBL] [Abstract][Full Text] [Related]
18. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells. Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372 [TBL] [Abstract][Full Text] [Related]
19. [Effect of APN/CD13 on bestatin enhancing all-trans-retinoic acid-inducing differentiation in NB4 cells]. Qian XJ; Lin MF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1125-8. PubMed ID: 22040956 [TBL] [Abstract][Full Text] [Related]
20. Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy. Schmitt C; Voegelin M; Marin A; Schmitt M; Schegg F; Hénon P; Guenot D; Tarnus C Bioorg Med Chem; 2013 Apr; 21(7):2135-44. PubMed ID: 23428964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]